Beta Blockers in Septic Shock: A Critical Analysis

This chapter examines the use of beta blockers, specifically landiolol, in patients with septic shock and tachycardia. It critiques a multi-centre randomized control trial, discussing its design flaws, including patient selection and outcome measures, while emphasizing the challenges of managing cardiac issues in sepsis. The conversation highlights the complexities of treatment methodologies and the necessity for accurate patient phenotyping in ICU settings.